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ABSTRACT 
Blepharitis or inflammation of the eye lid is one of the most frequently encountered eyelid disorder. It 
is often a troublesome condition for patients owing to the long standing nature of disease and 
fluctuations in its severity. The chronic inflammation can cause the damage to occular surface ie to the 
conjunctiva and cornea because of the intimate relationship between the lids and ocular surface. 
Blepharitis, if not recognized and appropriately managed, can lead to worsening of signs and 
symptoms, changes in visual function, disrupted preocular tear film, structural changes in eyelash 
follicle resulting in trichiasis, madarosis, tylosis and a negative impact on quality of life of patients.  
Complete disease elimination is rarely achieved with the modern line of management which include 
topical antibiotic and weak steroid ointment. Based on the site of pathology, clinical features and the 
sequale of the disease it can be well correlated with the Sandhigata roga -‘Krumigranthi’ wherein the 
‘Krumis’ will later invade to the inner structures of eye. Pratisarana is one of the treatment modality 
explained for the treatment of Krumigranthi in the classics. Thus an observational study has been 
conducted on patients (n=10) of Shalakya tantra OPD of SKAMC, Bangalore to evaluate the efficacy of 
Triphaladi pratisarana in the management of Krumigranthi. The present study has come out with 
promising results in the reduction of signs and symptoms of anterior blepharitis. However clinical 
trials on large sample with long duration of follow up is necessary to establish the efficacy of 
Pratisarana as a procedure of choice and to analyse the recurrence rate after treatment.  
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INTRODUCTION
 Blepharitis or inflammation of the eye lid is 
one of the most frequently encountered eyelid 
disorder. It is often a troublesome condition for 
patients owing to the long standing nature of disease 
and fluctuations in its severity with periods of 
exacerbations and remissions. The word originates 
from the Greek word “blepharos”, which means “eyelid” 
and the Greek suffix “itis”, which means inflammation.1 
Even though blepharitis is one of the most common 
disorders encountered in eye clinic, inadequate 
prevalence or incidence data exist. Some reports 
indicate that it is present in almost 47 percent of 
ophthalmic patients. 2 
 The chronic inflammation can cause the 
damage to ocular surface ie to the conjunctiva and 
cornea because of the intimate relationship between 
the lids and ocular surface. Out of the two clinical forms 
of blepharitis ie the anterior and posterior blepharitis, 
the former is usually affected by staphylococcal species 
and/or seborrhoea. Anterior blepharitis affects the 
anterior portions of the lid margin, including the 
eyelashes. Even though the pathophysiology of 
blepharitis is poorly understood triad of possible 
mechanisms underlies anterior blepharitis: 1). direct 
bacterial infection of the lids 2). reaction to the 
presence of endotoxins and/or exotoxins produced by 
pathogenic bacteria and/or commensal lid flora 3). cell-
mediated delayed hypersensitivity response to bacteria 
antigens. 3  
 Blepharitis is often misdiagnosed because of 
co-morbidity with other ocular surface disease like dry 
eye disease and allergic conjunctivitis. Also blepharitis 
can coexist with various dermatologic conditions 
including rosacea, eczema and seborrheic dermatitis. 
Exogenous irritants and allergens may exacerbate both 
forms of blepharitis. Patients over the age of 18 are 
more likely to be affected, but the disease is also found 
in children. 4 
 Blepharitis, if not recognized and appro-
priately managed, can lead to worsening of signs and 
symptoms, disrupted preocular tear film, discomfort, 
changes in visual function, structural changes in 
eyelash follicle resulting in misdirected eyelashes 
(trichiasis), loss of eye lashes (madarosis), scarring 
with irregularity of lid margin (tylosis) and a negative 
effect on patient’s quality of life. 5 Common sequelae of 
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blepharitis include blepharoconjunctivitis, hordeolum 
and chalazion (styes).  
 Complete disease elimination is rarely 
achieved with the modern line of management which 
include topical antibiotic ointment like sodium fuscidic 
acid, bacitracin, chloramphenicol, kenalog etc. and 
topical weak steroid ointment like flurometholone. Lid 
hygiene and removal of cause is of great importance 
regardless of type of blepharitis.6 
 Based on the site of pathology, clinical features 
and the sequale of the disease it can be well correlated 
with the Sandhigata roga -‘Krumigranthi’. There are 
description regarding the involvement of ‘Krumis’ 
(micro organisms) in the pathogenesis of 
Krumigranthi.7 Even as per the modern science the 
pathology of anterior blepharitis is predominantly 
associated with involvement of bacteria and recently 
the role of parasites like Demodex folliculorum has 
come into scene. The Lakshanas of Krumigranthi 
exactly correlates with symptoms of chronic blepharitis 
such as ‘Kandu’-itching, ‘Usha’ –burning sensation, 
‘Puyasrava’ –mucoid discharge, ‘Pakshmapota’ – scaling 
of eyelid. The descriptions like ‘Apange va kaneene va’ 
closely simulates the angular blepharitis8. Even the 
involvement of ocular surface in chronic cases is 
explained as ‘Charantyantarnayanam dushayanti’ i.e., 
the Krumis will later invade to the inner structures of 
eye and afflict the ocular surface.  
Aims and Objectives  
1. To evaluate the efficacy of ‘Triphaldi yoga’ in the 
management Krumigranthi.  
2. To assess the efficacy of ‘Pratisarana’ in the 
management of Krumigranthi.  
 Materials and Methods  
 This observational clinical study has been 
approved by the institutional ethical committee of 
SKAMCH & RC Bangalore. Before the start of the study 
written consent was taken from each patient willing to 
participate. Patients were free to withdraw their name 
from the study at any time without giving for any 
reason thereof.  
 The diagnosis of ‘Krumigranthi’ – blepharitis 
was done on both the modern and Ayurvedic basis. For 
this purpose a special research proforma was prepared 
as per the modern and Ayurvedic view. The 
documentation has been made regarding history of the 
present complaint, past ocular history, present and past 
medication history. The detailed ocular examination 
has been performed using slit lamp biomicroscopy. 
Schirmer’s test was also conducted to rule out the dry 
eye in suspected cases. Routine blood investigations, 
fasting blood sugar, serum cholesterol and routine 
urine investigations were done to rule out any systemic 
diseases.  
 
 
(i) About the medicaments  
 The formulation selected for the Pratisarana is 
mentioned under Krumigranthi chikitsa in Uttarastana 
of Ashtanga Hrudaya9. The ingredients of Pratisarana 
choorna includes Triphala, Kshaudra, Kaseesa and 
Saindhava. The Triphala choorna manufactured by 
Pentacare Ayurpharma Bangalore has been used for 
present study. The Kaseesa and Saindhava have been 
procured from Ayurvedic raw drug distributors and the 
same has been identified and authenticated by the Dept 
of Rasashastra, SKAMCH & RC, Bangalore. The Kaseesa 
is subjected to Shodhana before usage based on the 
method in Ayurvedic Formulary of India (AFI)10. The 
honey manufactured by Dabur India Pvt Ltd was used 
for mixing the Pratisarana choorna before application.  
Table 1: Ingredients and quantity of Triphaladi yoga 
Ingredient Quantity 
Triphala choorna 10gm 
Saindhava 1pinch 
Kaseesa 1 pinch 
Kshaudra Q. S 
Preparation of the medicine 
 All the ingredients are finely powdered and 
mixed thoroughly to get a uniform mixture. For each 
Pratisarana drugs have been taken in the following 
ratio(Table1): 
 The fine powder of Triphala, Saindhava and 
Kaseesa were mixed in a sterile vessel with the 
sufficient quantity of honey to get a thick mixture. 
(ii) About the procedure – ‘Pratisarana’ 
Procedure  
 The patient is made to sit in a comfortable 
chair and asked to wear the mask before the treatment. 
The thick paste of Pratisarana choorna was taken in a 
clean and sterile vessel. The medicine was then applied 
over the eye lid margin and rubbed thoroughly to reach 
the entire lid. The procedure was done for a duration of 
5-10 min and repeated for the other eye also. Care has 
been taken to prevent the entry of medicine into the 
eye while application and rubbing. The same procedure 
is then repeated over the lower eye lid also. After the 
procedure the lid was cleaned using cotton dipped in 
Triphala kashaya.  
Study design 
 Open label clinical trial was conducted on 10 
patients fulfilling the criteria for the diagnosis of the 
disease ‘Krumigranthi’ -Blepharitis in the present 
study. The patients were selected from the outpatient 
department of Shalakya Tantra of Shri 
Kalabyraveshwara Ayurveda Medical College Hospital 
and Research Centre Bangalore.  
Selection of patients 
 10 patients of age group 10-60 years were 
selected based on the inclusion and exclusion criteria 
(Table 2).  
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Table 2: Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
The patients of age 10-60 years were 
selected irrespective of sex, 
occupation, religion and 
socioeconomic status.  
Systemic diseases, such as diabetes, hypertension as well as 
autoimmune diseases including systemic lupus erythematosus, 
rheumatoid arthritis, thyroid disease, sarcoidosis, Sjögren's, and 
psoriasis.  
Patients presenting with Lakshanas of 
Krumigranthi & signs and symptoms 
of anterior blepharitis 
 
Patients under medications like beta blockers, diuretics, antihistamines, 
decongestants, chemotherapy medications, antidepressants, 
antipsychotic medications, hormonal anti contraceptives as well as 
hormone replacement therapy given to post menopausal women 
Patients fit for Pratisarana Associated with other ocular diseases like Dry eye, Computer vision 
syndrome, Allergic conjunctivitis.  
Blepharitis of recent onset not more 
than a year.  
Blepharitis with complications like blepharoconjunctivitis, hordeolum, 
trichiasis, tylosis, and chalazion.  
Intervention 
 The study was intervened by the treatment - 
Pratisarana with triphaladi yoga. The patients were 
advised to follow the measures to maintain lid hygiene 
as per the protocol.  
Treatment phase  
Once daily for 5-10 minutes in each eyelid for 7days.  
Follow up phase 
 One follow up has been conducted after 7 days of 
completion of treatment.  
Total duration of study 
Total duration of the study was 14 days.  
Criteria for Assessment  
 Assessment of the effect of treatment on signs 
and symptoms have been done based on subjective and 
objective parameters by adapting a grading pattern 
before and after the treatment as follows: (Table 3 & 
Table 4). 
Table 3: Grading of subjective parameters 
Subjective 
Parameter 
0 1 2 3 
Itching of eyelids 
 
No itching Occasional tickle 
sensation not requiring 
to rub eye 
Intermittent itching 
sensation which 
requires rubbing of eyes 
Intolerable itching which 
would require significant 
eye rubbing 
Burning 
sensation 
 No burning 
sensation 
Occasional burning 
sensation 
Frequent burning 
sensation  
Continous burning 
sensation  
Soreness  No soreness Mild soreness  Moderate soreness Severe soreness 
Lacrimation  No 
lacrimation 
  
Mild lacrimation (only 
on straining and 
exposure to light) 
Moderate lacrimation 
which needs occasional 
mopping 
Profuse lacrimation 
which needs continuous 
mopping 
Table 4: Grading of objective parameters 
Objective 
parameter 
0 1 2 3 
Photophobia  No 
photophobia 
Mild photophobia on 
exposure to very 
bright light 
Moderate photophobia on 
exposure to torch light 
Severe disabling 
photophobia experienced 
even in daylight 
Falling of 
eyelashes 
No falling of 
eyelashes 
Mild falling of eye 
lashes especially on 
rubbing 
Moderate falling of eye 
lashes with diffuse loss of 
density of hair 
Marked loss of eye lashes 
with wide gaping between 
the lashes 
Hyperaemia 
of lid margin 
No hyperaemia Mild hyperaemia, 
visible on slit lamp 
examination 
Moderate hyperaemia, 
visible on torch light 
examination 
Severe hyperaemia, visibly 
evident on direct inspection 
Scaling No scaling Mild scaling, visible on 
slit lamp examination 
Moderate scaling, visible 
on torch light examination 
Severe scaling visibly 
evident on direct inspection 
Lid oedema No lid oedema Mild lid oedema Moderate lid oedema Severe lid oedema  
Observation and result 
 Out of all 10 subjects enrolled for the present study 60% were male and 40% were female. 50% belongs to 
middle class, 40% to lower class and 10% to higher class. 50% of them were having secondary education and 30% 
were having primary education. In terms of chronicity, 40% were having a chronicity of 9months and 30% with 
6months chronicity. (Table 5) 
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Table 5: Demographic data 
Variables  Age Groups Total 
  10-20 21-30 31-40 41-50 51-60  
Gender Male 2(20%) 0(0%) 1(10%) 1(10%) 2(20%) 6(60%) 
Female 0(0%) 1(10%) 0(0%) 1(10%) 2(20%) 4(40%) 
Socio-economic 
status 
Lower class 2(20%) 0(0%) 1(10%) 0(0%) 1(10%) 4(40%) 
Middle class 0(0%) 1(10%) 0(0%) 1(10%) 3(30%) 5(50%) 
Higher class 0(0%) 0(0%) 0(0%) 1(10%) 0(0%) 1(10%) 
Educational 
status 
Primary 1(10%) 0(0%) 0(0%) 0(0%) 2(20%) 3(30%) 
Secondary 1(10%) 0(0%) 0(0%) 2(20%) 2(20%) 5(50%) 
Higher secondary 0(0%) 0(0%) 1(10%) 0(0%) 0(0%) 1(10%) 
Graduation 0(0%) 1(10%) 0(0%) 0(0%) 0(0%) 1(10%) 
Chronicity <3months 1(10%) 0(0%) 0(0%) 0(0%) 0(0%) 1(10%) 
<6months 1(10%) 0(0%) 0(0%) 0(0%) 2(20%) 3(30%) 
<9months 0(0%) 1(10%) 1(10%) 1(10%) 1(10%) 4(40%) 
<12months 0(0%) 0(0%) 0(0%) 1(10%) 1(10%) 2(20%) 
 It has been observed that, the symptoms like 
itching of eyelids with pre-treatment mean score 2. 4 
has been improved to mean 0. 7. Burning sensation of 
eyelid has been reduced considerably from the pre to 
post treatment by 50%. But there was no much 
remarkable reduction in photophobia and falling of eye 
lashes between pre & post treatment. The soreness 
which was uncomfortable prior to treatment 
(mean=2.0) has resulted in extending comfort 
(mean=1.1). The lacrimation which was before 
treatment (mean=2.2) has resulted in considerable 
reduction (mean=1.5). Hyperaemia of lid margin and 
scaling were the symptoms presented by all the 
patients and there were apparent reduction in both 
these symptoms post treatment. Lid oedema which was 
before treatment (mean=2.6) reduced considerably 
(mean=1.2) On applying statistical test before and after 
the treatment, symptoms like itching, burning 
sensation, soreness, hyperaemia of lid margin, scaling 
and lid oedema have shown highly significant result 
(p<0.001), lacrimation has shown significant reduction 
(p<0.01) and Changes in photophobia was insignificant 
(p>0.05). (Table. 6) 
Table 6: Statistical analysis Pre & Post Treatments 
 S. No.  Variables  n BT (Mean) AT (Mean) SD  SE  ‘t’ value P 
1 Itching of eyelids 10 2. 4 0. 7 0. 67 0. 2 8. 056 <0. 001 
2 Burning sensation 6 2. 5 1. 2 0. 48 0. 19 6. 751 <0. 001 
3 soreness 7 2. 0 1. 1 0. 34 0. 12 6. 695 <0. 001 
4 Lacrimation 6 2. 2 1. 5 0. 48 0. 20 3. 333 <0. 01 
5 Photophobia 4 1. 5 1. 0 0. 50 0. 25 2. 000 >0. 05 
6 Falling of eyelashes 9 2. 2 1. 8 0. 47 0. 15 2. 121 <0. 05 
7 Hyperaemia of lid margin 10 2. 1 1. 4 0. 64 0. 20 3. 458 <0. 001 
8 scaling 10 2. 2 1. 2 0. 63 0. 19 5. 025 <0. 001 
9 Lid oedema 9 2. 6 1. 2 0. 50 0. 16 8. 674 <0. 001 
 
 
Figure 1: Observation Chart 
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DISCUSSION  
 ‘Krumigranthi’ is explained as a Sandhigata 
roga both in Ashtanga Hrudaya and Susruta Samhita. 
Acharya Susruta considers it as a Kaphaja vyadhi while 
Acharya Videha describes it as a Sannipataja vyadhi. 
The Samprapti of the disease is well explained by 
Acharya videha as follows; the vitiated Pitta and Kapha 
forms Granthi on the Vartma shukla sandhi which later 
on due to Ushma undergoes Pachana and leads to 
manifestation of Krumis. These Krumis lodges in the 
Pakshma (eye lashes)and Vartma (eye lid) and vitiates 
eye.11 
 Bhedana is the treatment of choice explained 
for Krumigranthi. Pratisarana has to be performed after 
Swedana and Bhedana of the Granthi. The long standing 
cases of posterior blepharitis is generally associated 
with cystic dilatation of meibomian gland wherein 
Bhedana would be a treatment of choice. Pratisarana 
alone can be useful in anterior blepharitis where the 
meibomian cysts or abscess are rare to find out. There 
is no detailed description regarding the procedure of 
Pratisarana in the classics. The scattered references in 
the commentary of Susruta samhia explains the 
Pratisarana as a procedure of ‘Avagharshana’ in which 
the medicine is rubbed or gently massaged against a 
base.  
A)Action of ‘Triphaladi yoga’ 
 Triphala is an extensively used formulation in 
various disorders due to its wide range of action. This 
renowned formulation is a combination of three fruits 
Hareetaki (Terminalia chebula), Vibheetaki (Terminalia 
bellarica) and Amalaki (Emblica officinalis) in equal 
proportions. In ancient Ayurvedic texts Triphala has 
been described as a Rasayana having Tridosha hara 
property. Due to its Rooksha guna, it has promising 
effect on Srava and Kandu. The Kanduhara property of 
Triphala is explained in Hareeta Samhita.12 Vibhitaki is 
an excellent drug having Kruminasana property. The 
powder of Triphala is reported to have anti-
inflammatory, anti-infective and immunomodulatory 
action. The immunomodulatory action of Triphala may 
help in correcting the cell-mediated delayed 
hypersensitivity response to bacteria antigens which is 
one of the postulated pathophysiology for blepharitis. 
The scientific studies on the aqueous extract of 
Triphala reported its efficacy as an antibacterial agent 
against staphylococcus aureus which is the main 
causative organism of blepharitis. 13 Recent extensive 
research indicates presence of different active 
compounds in them such as gallic acid, chebulagic acid, 
ellagic acid, flavonoids, tannins and phenols, which are 
responsible for its effective immune stimulatory action.  
 Kshuadra is having Chakshushya, 
Tridoshashamana and Lekhana property. It may 
facilitate the deeper penetration of the drug as it is 
having quality like Sookshma marganusari.14 Saindhava 
due to its Sookshma guna facilitates the deeper 
penetration of the drug to the Sookshma srotas. It is 
having Tridoshahara and Chakshushya property.15 
Kaseesa is Vatashleshmahara and it possess Ushna 
veerya. It also holds Netrya, Kanduhara and Vishahara 
qualities.16 
 In short, the combination of the drug exhibits 
excellent Tridosha hara, Kandu hara and krumihara 
actions with deep penetrating property through minute 
channels. These properties accounts for the 
considerable reduction in itching, burning sensation, 
soreness, hyperaemia, scaling and lid oedema.  
B) Probable mode of action of ‘Pratisarana’ 
 ‘Pratisarana’ means to rub or gently massage 
the medicine against a base. As the medicine is gently 
massaged or rubbed with tip of the finger into the skin 
of the eyelid there will be quicker and better 
absorption. The Pratisarana facilitates the quicker 
absorption of drug potency (Veerya) through 
Romakoopa (hair root), Swedavahini, (sweat gland) and 
Siramukha (vasculature). Hair follicle, sebaceous and 
sweat glands represent an important shunt route into 
the skin for topical drugs. The hair follicle 
infundibulum also has a large storage reservoir 
capacity, about 10 times more than the stratum 
corneum. Because of the pressure exerted on rubbing 
and the deep penetrating properties of the drugs in 
Triphaladi yoga, it can easily penetrate across the skin 
of eyelid through the appendageal roots. 
 The thickness and integrity of stratum 
corneum is an important factor determining the 
transdermal drug absorption. Thicker skin is a greater 
barrier to passage of the drug. The skin of eyelid is the 
thinnest in the body and it measures approximately 0. 
05 cm. Because of its extreme thinness the medicine 
applied over the lid will penetrate deeper when rubbed 
on to skin.17  
 The basal layer of the epidermis of eyelid 
shows the presence of unicellular sebaceous glands and 
numerous typical eccrine sweat glands. The dermis is 
composed of rich network of elastic fibres, blood 
vessels, lymphatics and nerves. Percutaneous 
penetration of a drug occurs through the stratum 
corneum, underlying viable epidermis, dermis, and 
then finally into the circulatory and lymphatic system. 
Percutaneous penetration may occur through the 
intercellular, transcellular, and appendageal routes. 
The intercellular route is thought to have a major role 
in drug penetration, which involves partitioning of the 
drug into extracellular regions of the stratum corneum. 
The transcellular route involves the drug going through 
the corneocytes of the stratum corneum and the 
appendegeal route involves the drug entering the 
shunts of hair follicles and sebaceous and sweat glands, 
effectively bypassing the stratum corneum.18  
 By Pratisarana mechanical pressure is exerted 
on the eyelid margin which remove debris, bacteria, 
bacterial toxins, scales and crusts from the minute folds 
of the skin and thereby helps to maintain the lid 
hygiene. The rubbing of the drug will also improve the 
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vascular supply of the eyelid which in turn helps in 
faster and effective absorption.  
CONCLUSION 
 Blepharitis represents the cutaneous disorder 
of the eye lid wherein the topical applications like 
Pratisarana have a great role to impart the clinical 
success in treatment. The present study carried out 
establishes the efficacy of Pratisarana in the 
management of blepharitis as the study has come out 
with promising results in the reduction of signs and 
symptoms of blepharitis. However clinical trials on 
large sample with long duration of follow up is 
necessary to establish the efficacy of Pratisarana as a 
procedure of choice and to analyse the recurrence rate 
after treatment.  
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